Ruth Veksler

Title: Ruth Veksler: Innovator in Androgen-Dependent Disorder Treatments

Introduction

Ruth Veksler is a prominent inventor based in Karmiel, Israel. She has made significant contributions to the field of medical treatments, particularly focusing on androgen-dependent disorders. Her innovative work has led to the development of a unique patent that addresses these health issues.

Latest Patents

Ruth Veksler holds a patent for a composition and method for treating androgen-dependent disorders. This patent, titled "Composition and method for treating androgen-dependent disorders," involves chimeric polypeptides that comprise a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3α-HSD), fused to a signal peptide moiety. The invention also includes polynucleotides encoding the chimeric polypeptide and compositions that contain at least one microorganism cell capable of secreting the chimeric polypeptide. The methods and kits provided by this patent aim to treat, prevent, or ameliorate androgen-dependent disorders, including androgenic alopecia.

Career Highlights

Ruth Veksler is associated with the Technion Research & Development Foundation Limited, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on treating various health conditions related to androgen levels.

Collaborations

Ruth collaborates with notable colleagues, including Roee Amit and Alexey Tomsov. Their combined expertise contributes to the success of their research initiatives and the development of innovative solutions in the medical field.

Conclusion

Ruth Veksler's contributions to the treatment of androgen-dependent disorders highlight her role as a leading inventor in the medical research community. Her innovative patent demonstrates the potential for significant advancements in healthcare.